Nikolaos P. Nanis - Jan 2, 2024 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Chief Technology Officer
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Jan 2, 2024
Transactions value $
-$11,107
Form type
4
Date filed
1/4/2024, 04:05 PM
Previous filing
Dec 5, 2023
Next filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +1.23K +1.92% 65.6K Jan 2, 2024 Direct F1
transaction TDOC Common Stock Sale -$11.1K -520 -0.79% $21.36 65K Jan 3, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -1.23K -12.49% $0.00 8.63K Jan 2, 2024 Common Stock 1.23K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3 On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.